- Saada sõbrale
- RSS
- google +
- Trükiversioon
- Saada lehekülg E-postiga
Uudised (Muud nakkushaigused)
Tervis−EL uudiste- ja ürituste vood genereeritakse automaatselt vastavalt Euroopa Komisjoni kriteeriumidele. Need võivad sisaldada liigitusvigu.
Monitoring current threats: ECDC Communicable Disease Threats Report (CDTR), week 20» europa.eu
The CDTR reports this week on an ongoing outbreak of hepatitis A virus (HAV) affecting individuals from various northern countries in the EU. Since the beginning of the outbreak on 1 October 2012 unt[...]How flooding affects health»
More frequent, extreme rainfall is projected. Flooding has extensive and significant effects on health, spanning the short and long terms and ranging from drowning and injuries to infectious diseases and mental-health problems.
ECDC readies for congenital rubella syndrome surveillance» europa.eu
Most EU/EEA countries monitor rubella, rubella in pregnancy and congenital rubella syndrome through mandatory and comprehensive systems, but changes could be made to help align surveillance data acro[...]ECDC updates Rapid Risk Assessment on Middle East respiratory syndrome coronavirus (novel coronavirus)» europa.eu
ECDC has published an update of its rapid risk assessment on Middle East respiratory syndrome coronavirus (MERS-CoV), previously referred to as the novel coronavirus. 17/05/2013 00:00[...]Novel coronavirus update – new virus to be called MERS-CoV»
As of 15 May 2013, WHO had been informed of a global total of 40 laboratory-confirmed cases of human infection with novel coronavirus, including 20 deaths, in 6 countries: France, Germany, Jordan, Qatar, Saudi Arabia and the United Kingdom.
Infographic: Europe’s fight against antimicrobial resistance» europa.eu
Published on: 16 May 2013 The third joint EFSA and ECDC report on antimicrobial resistance in zoonotic bacteria affecting humans, animals and foods shows the continued presence of resistance to a ran[...]Joint EFSA and ECDC report: resistant bacteria remain an important issue that can affect humans through animals and food.» europa.eu
EFSA is the EU risk assessment body for food and feed safety. It provides independent scientific advice to risk managers.[...]Antimicrobial resistance continues to be found in Salmonella and Campylobacter» europa.eu
Antimicrobial resistance continues to be found in Salmonella and Campylobacter, the latest joint report from the European Food Safety Authority and the European Centre for Disease Prevention and Con[...]Joint EFSA and ECDC report: resistant bacteria remain an important issue that can affect humans through animals and food.» europa.eu
Published on: 16 May 2013 The third joint EFSA and ECDC report on antimicrobial resistance in zoonotic bacteria affecting humans, animals and foods shows the continued presence of resistance to a ran[...]Monitoring current threats in week 18/2013: ECDC Communicable Disease Threats Report (CDTR)» europa.eu
Last week, public health authorities reported on the on-going outbreak in Wales. Public Health Wales reported 503 measles cases in April, bringing the total number of notified cases in the outbreak a[...]Ukraine Adopts State Program to Fight Hepatitis» aidsactioneurope.org
The Cabinet of Ministers adopted the first in the history of Ukraine State Program to fight hepatitis. In fact, this document is crucial in the area of treatment of Hepatitis B and C. The Government [...]RareConnect announces 40th online community»
RareConnect.org, the platform created, monitored and run by patient organisations EURORDIS and NORD, continues its mission of bringing rare disease patients together, across borders and beyond language barriers
Rift valley fever: EFSA looks at the risk of introduction and spread in Mediterranean countries neighbouring the EU (europa.eu, ) »
Published on: 26 April 2013 The introduction of the Rift Valley fever into countries in North Africa and Middle East that border the Mediterranean Sea is most likely to occur through the uncontrolled[...]Measles monthly report now includes Croatia; UK reports highest measles cases since 1994 and Poland faces nationwide rubella epidemic» europa.eu
During the period March 2012 to February 2013, 8 499 cases of measles were reported by 29 EU/EEA countries and Croatia. For the same period, there were 21 549 rubella cases were reported; 99% of whic[...]EU research project develops new malaria test tool» europa.eu
European Commission Press release Brussels, 24 April 2013 An EU-funded research project aims to start testing a new diagnostic tool for malaria one year ahead of schedule. The pioneering smartphone-l[...]Joint Statement by Commissioners Andris Piebalgs (Development), Máire Geoghegan-Quinn (Research and Innovation) and Tonio Borg (Health and Consumer) on the eve of the World Malaria Day» europa.eu
European Commission MEMO Brussels, 24 April 2013 Millions of people living in highly endemic areas continue to lack access to effective malaria prevention, diagnostic testing, and treatment. As a res[...]A literature review on effective risk communication for the prevention and control of communicable diseases in Europe - Just Published - EU Bookshop» europa.eu
Insights into health communication[...]Hepatitis A: EFSA and ECDC publish a joint rapid outbreak assessment » europa.eu
Published on: 16 April 2013 EFSA is working closely with ECDC to help identify the origin of the recent outbreak of Hepatitis A virus infection in humans in Denmark, Finland, Norway and Sweden. Hepat[...]Outbreak of hepatitis A virus infection in four Nordic countries – Joint ECDC-EFSA assessment» europa.eu
Between 1 October 2012 and 8 April 2013, 16 confirmed cases of hepatitis A virus (HAV) infections were reported in Denmark, Finland, Norway and Sweden. As none of the cases have a travel history outs[...]Research Headlines - A breakthrough towards preventing cardiovascular diseases» europa.eu
The hardening of arteries also known as 'atherosclerosis' can cause cardiovascular diseases (CVD), which can lead to heart attacks and strokes. New evidence has been uncovered strengthening the link [...]Guideline on good pharmacovigilance practices: P I - Vaccines for prophylaxis against infectious diseases – Definitions for inclusion in GVP annex I: consultation open» europa.eu
Guideline on good pharmacovigilance practices (GVP): P I - Vaccines for prophylaxis against infectious diseases – Definitions for inclusion in GVP annex I Guideline on good pharmacovigilance practice[...]Guideline on good pharmacovigilance practices: Product-or population-specific considerations I: Vaccines for prophylaxis against infectious diseases: consultation open» europa.eu
The objective of this module is to strengthen the conduct of pharmacovigilance for vaccines. It should be noted that the overall objectives and processes of pharmacovigilance are no different for vac[...]Rise in human infections from Campylobacter and E. coli, whilst Salmonella cases continue to fall: EFSA and ECDC 2011 zoonoses report» europa.eu
EFSA is the EU risk assessment body for food and feed safety. It provides independent scientific advice to risk managers.[...]Rise in human infections from Campylobacter and E. coli, whilst Salmonella cases continue to fall: ECDC and EFSA 2011 zoonoses report» europa.eu
The European Centre for Disease Prevention and Control and the European Food Safety Authority launched their annual report on zoonoses and food-borne outbreaks. 09/04/2013 11:00[...]ECDC publishes core competencies for infection control and hospital hygiene professionals in the European Union» europa.eu
With this technical report, the intent of ECDC is to propose a comprehensive list of core competencies that should be adopted by infection control and hospital hygiene professionals across Europe. 26[...]Overall notification rate for measles continues to exceed the elimination target» europa.eu
The latest data drawn from ECDC's The European Surveillance System show that of the 29 countries that contribute to measles monitoring, only 13 met the elimination target of less than one case of mea[...]ECDC surveillance report on Legionnaires’ disease in Europe in 2011» europa.eu
In 2011, a total of 4 897 cases of Legionnaires' disease (LD) were notified by EU Member States, Iceland and Norway, with a 22% decrease compared to the previous year. Most of the cases (67%) were co[...]Future treatment of gonorrhoea at risk: new ECDC report» europa.eu
Effective control of gonorrhoea, the second most commonly reported sexually transmitted infection in Europe, relies on successful antimicrobial treatment. As data from the ECDC report Gonococcal anti[...]Updated guidance on novel coronavirus by WHO: surveillance, applied epidemiological studies and clinical guidance» europa.eu
The WHO has recently updated a number of its interim guidance documents for the novel coronavirus including clinical management (11th February) and the case definition for reporting (19th February); [...]Epidemiological update: additional confirmed cases of novel coronavirus including sixth case diagnosed in Europe» europa.eu
Since the ECDC epidemiological update of 22 February 2013, four new confirmed cases of novel coronavirus (nCoV) infection have been reported worldwide, totalling 17 cases and including eleven deaths.[...]EDCTP-funded projects for tuberculosis vaccines» edctp.org
Every year 9 million people are newly diagnosed with tuberculosis (TB). The disease kills approximately 1.4 million people per year including infants and adolescents. TB/HIV co-infection and MDR/XDR-[...]EU Parliament votes to adopt Antimicrobial Resistance (AMR) measure as part of agricultural reform» epha.org
The European Parliament voted on its plenary session on 13 March on the reform of the Common Agricultural Policy (CAP). As part of this vote, an amendment concerning Antimicrobial Resistance (AMR) wa[...]Latest ECDC maps on vector distribution introducing enhanced information on spread of mosquitoes, ticks and sandflies in Europe» europa.eu
ECDC publishes today the latest maps on the geographical distribution of exotic mosquitoes, sandlfies and ticks in Europe, the new maps updated with a more detailed classification of the geographical[...]Preventing heart disease requires a universal approach» escardio.org
Three out of five of the world's most costly diseases are cardiovascular in nature, and their prevention is now recognised as an urgent public health need. This year's EuroPRevent congress, already t[...]Infectious Disease Epidemiology: ESCAIDE 2013 to take place on 5-7 November in Stockholm, Sweden» europa.eu
The 2013 European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) will be held in Stockholm, Sweden on 5 - 7 November. 20/03/2013 14:30[...]Tuberculosis: Europe's Ticking Timebomb» aidsactioneurope.org
Drug-resistant forms on the rise in Europe; treatment costs to increase 50 times if epidemic left unchecked. MEPs get involved in the fight against deadly strains of the disease. Brussels, 20th March[...]New ECDC/WHO Euro report: One in five TB patients has extrapulmonary tuberculosis»
The fifth report launched jointly by ECDC and the WHO Regional Office for Europe follows on from reports under the EuroTB project established in 1998
Epidemiological update: anthrax cases among people who inject drugs» europa.eu
On 8 March, the Health Protection Agency in the United Kingdom reported an additional fatal case of anthrax in Suffolk, England. It concerns a person who injected heroine. This brings the number of a[...]Annual Epidemiological Report 2012» europa.eu
The Annual Epidemiological Report 2012 - which is based on 2010 surveillance data - shows that meaningful disease surveillance in Europe is not easily accomplished. Surveillance systems in the EU sti[...]Data on antimicrobial consumption from EU/EEA countries now available from the ESAC-Net interactive database» europa.eu
A new interactive database allows the display of selected data on antimicrobial consumption in different formats such as tables, maps and figures. The database includes data on antimicrobial consumpt[...]Communicating during epidemics» europa.eu
Disease outbreaks are inevitable, and can often be unpredictable. They are frequently marked by uncertainty, confusion and a sense of urgency. Communication, generally through the media, is an import[...]Monitoring current threats in week 9/2013: ECDC Communicable Disease Threats Report (CDTR)» europa.eu
From 24 February to 1 March 2013, ECDC monitored several on-going public health threats within and outside the European Union. 04/03/2013 12:00[...]Global Fund to Fight AIDS, Tuberculosis and Malaria launches new funding model» aidsactioneurope.org
Up to $1.9 billion available in 2013 and 2014 GENEVA, 28 February 2013 - The Global Fund to Fight AIDS, Tuberculosis and Malaria today launched a new funding model that allows it to invest more strat[...]
Periodic Report Summary - ORCHID (Open collaborative model for tuberculosis lead optimisation)»
europa.eu
Project context and objectives: Tuberculosis (TB) is a disease of poverty affecting primarily young adults in their most productive years. Although the global incidence rate is slowly falling, in 201[...]ECDC examines current evidence for the possible environmental origin of azole resistance in Aspergillus species » europa.eu
In its risk assessment, ECDC examines current evidence for the environmental origin of resistance to medical triazoles in Aspergillus spp. and makes recommendations for further steps to assess the ri[...]European Medicines Agency: Meeting highlights from the Committee for Medicinal Products for Human Use 18-21 February 2013» europa.eu
This page provides an overview of the opinions adopted at the February 2013 meeting of the CHMP and other important outcomes.[...]Research Headlines - Controlling the killer» europa.eu
Visceral leishmaniasis (VL) & cutaneous leishmaniasis (CL) are parasitic diseases transmitted to humans by the bite of sand flies. In VL, the parasite migrates to the internal organs such as live[...]Rubella cases exceed 27 000 in 2012, total measles cases return to pre-outbreak levels» europa.eu
8 230 cases of measles were reported in EU/EEA countries in 2012, and rubella cases numbered 27 276. 20/02/2013 17:00[...]Novel coronavirus: ECDC updates its risk assessment» europa.eu
As of 16 February 2013, twelve laboratory confirmed cases of pneumonia caused by the novel coronavirus (novel CoV) have been reported to the World Health Organization (WHO). Six of the cases have bee[...]New Leishmania vaccine on its way» europa.eu
The European Union is tackling global warming by committing to reducing its energy consumption, promoting renewable energy and using the emission trading scheme. But global warming has brought about [...]Novel coronavirus update: new case but continued low risk »
The United Kingdom has reported a confirmed infection of the novel coronavirus (NCoV) in a relative of the case reported on 11 February 2013. This latest case is a resident of the United Kingdom who does not have a recent travel history and is understood to have a pre-existing medical condition that may have increased susceptibility to respiratory infections.